Marina Biotech's IPO

Marina Biotech raised a round of funding on September 22, 2003. Investors include Public.

Marina Biotech (OTCQB: MRNA) is a nucleic acid-based drug discovery and development company focused on rare diseases. The company's drug discovery platform allows them to develop compounds which best …

Articles about Marina Biotech's IPO: